Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The legal status depends on the country and its regulations
Wang X, Yang J, Li H, Mu H, Zeng L, Cai S, et al
Honest, physician-led care sets realistic expectations up front and reviews your actual response over time
September 20 Product: Zevra Therapeutics Miplyffa Indication: Niemann-Pick disease type C Patients with Niemann-Pick disease type C (NPC) have their first treatment after the FDA approved Zevra Therapeutics Miplyffa for the ultra-rare, progressive neurodegenerative disease
2.5 mg is always 25 units
US$ 23.11
US$ 26.11
US$ 29.70
US$ 24.10
US$ 22.84
US$ 24.01
US$ 29.76
US$ 26.28
US$ 22.88
US$ 25.90
US$ 24.93
